E-GEOD-10959 - siNTSR1-treated HNSCC cell lines: Control vs. siNTSR1-treated HSC2 or HSC3
Submitted on 27 March 2008, released on 28 March 2008, last updated on 1 May 2014
NTSR1 siRNA was used to abolish NTS signaling pathway in HSC2 and HSC3, and analyzed differentially gene expression with microarray. Keywords: Genetic modification Four-condition experiment, control vs. NTSR1 siRNA-treatment in HSC2 and HSC3 cells
transcription profiling by array
Naohiko Seki, Satoya Shimizu
Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway. Shimizu S, Tsukada J, Sugimoto T, Kikkawa N, Sasaki K, Chazono H, Hanazawa T, Okamoto Y, Seki N.